C-X-C Chemokine Receptor Type 4 Report

By www.reliablebusinessinsights.com

Report Details

Report Name

Global C-X-C Chemokine Receptor Type 4 Market Research Report 2024 Story

Pages

100

Price

$ 2900

Features

C-X-C Chemokine Receptor Type 4 Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              AdAlta Pty Ltd.
Ambrx, Inc.
Anchor Therapeutics, Inc.
Biokine Therapeutics Ltd.
BioLineRx, Ltd.
Bristol-Myers Squibb Company
Eli Lilly and Company
Globavir Biosciences, Inc.
GlycoMimetics, Inc.
NeED Pharma s.r.l.
Pharis Biotec GmbH
Polyphor Ltd.
Sanofi
TaiGen Biotechnology Co., Ltd.
Upsher-Smith Laboratories, Inc.
X4 Pharmaceuticals, Inc.